Расходы населения России на лекарственные средства: эмпирический анализ
The paper uses econometric tools (two-part model, Tobit model, Heckman model) to evaluate factors associated with consumer choice on the Russian pharmaceutical market. Using data from national public opinion survey conducted in 2014 by Levada Center we show that gender, health, retirement and single mother’s status are strongly associated with high expenditures on medicine. Incomes are positively associated with probability of spending on medicine, but marginal effect of incomes is small.
In the article the main tendencies and problems of development of the Russian pharmaceutical industry and the pharmaceutical market are considered. It is shown that low competitiveness of pharmaceutical industry and a high share of an import in the domestic pharmaceutical market are in many respects caused by low innovative activity of the Russian pharmaceutical companies. The contents «Strategy of development of pharmaceutical industry of the Russian Federation for the period till 2020» in interrelation with a complex of system problems of the Russian pharmaceutical industry and prospects of realization of innovative option of its modernization is considered and analysed.
This work contains preliminary data analysis of quantitative survey "Man, family, society" made by Institute of Social Prognosis in 2013 on nationwide sample in 9557 people. The survey provides valuable information about the partnership and reproductive biographies, territorial mobility, education and employment strategy, financial situation and retirement behavior of the population.The focus of our analysis focuses on the demographic and socio-economic behavior of the population, through the prism of the individual and the way of life of the household.
Competition and Intellectual Property Law in the Pharmaceutical Sector deals with the apparent contradiction between intellectual property (IP) rights (particularly patents) and competition law, with a focus on the pharmaceutical sector: in its aim to promote innovation and long-term competition, the patent system in fact provides a temporary right to exclude. The book explores the possibility of adjusting patent policies to better account for the trade-off between static and dynamic welfare and minimize the risks of anticompetitive behaviour, which happens with the misuse of patents. This book, the first to deal with this issue on a global basis, tackles the clashes of case law by Courts and antitrust enforcement by competition authorities that undermine the predictability of solutions to this problem and increase the risk of fundamental rights violations and excessive transitional costs for enterprises.
Examining the approaches to competition and IP regulation in fourteen leading jurisdictions, the analysis provides a comparative perspective on recent relevant regulations and case law in the pharmaceutical sector. Thirty-one contributions by internationally known experts in both fields – judges in specialized courts, chairmen and board members of national competition authorities, and well-known scholars and practitioners – focus on the salient topics and on the interplay between patent law and competition law, with an insight into the human rights issues that arise.
The author studies relationships between medical representatives and physicians from the structural embeddedness perspective. Based on the research she discloses the existing practices of relationships between pharmaceutical companies and physicians, describes possible ways of resolving administrative and legal problems associated with new regulations of drug turnover. The author also gives attention to the dissolution of ties as an important element of network analysis.
In the present paper, on the basis of the theory of production principles and production revolutions, we reveal the interrelation between K-waves and major technological breakthroughs in history and make forecasts about features of the sixth Kondratieff wave in the light of the Cybernetic Revolution that, from our point of view, started in the 1950s. We assume that the sixth K-wave in the 2030s and 2040s will merge with the final phase of the Cybernetic Revolution (which we call a phase of self-regulating systems). This period will be characterized by the breakthrough in medical technologies which will be capable to combine many other technologies into a single complex of MBNRIC-technologies (med-bio-nano-robo-info-cognitive technologies). The article offers some forecasts concerning the development of these technologies.
In this chapter we aim to examine the discourses created and reproduced through the interaction between single mothers and representatives of social services. The analysis is based on twenty-six interviews with single mothers and six interviews with social workers conducted in 2001–2003, and six interviews with single mothers and three with social workers conducted in 2006 in the Saratov region in Russia, as well as official documents and the publications of other researchers. In our interviews with mothers, we focused on the issues of familial well-being and interactions with social services, while social workers were asked to discuss their experiences with clients. A short overview of statistics and social policy terminology prefaces a discussion of how mother-headed families and state social policy interrelate and affect each other. The subsequent sections contain analysis of the interviews with single mothers who, as the heads of low-income households, interact with the social service system. The analysis demonstrates that single mothers are frustrated by inadequate assistance and the impossibility of improving their life situations. The discussion goes on to show that social workers, who are used to interpreting complex issues in the life situations of single mothers as individual psychological peculiarities, tend to blame the victim, thus ignoring important social conditions and imposing on women a responsibility for problems that are societal in origin.
Nowadays Russian drug market structure is inefficient in terms of high level of branded generic drugs. This requires improvement of policy measures in order to increase the affordability of innovative drugs, both domestic and imported. The paper describes special features of Russian pharmaceutical market and investigates how drug policy instruments affect the commercial market structure, focusing mainly on incentives to launch and sell innovative drugs.
Smoking is a problem, bringing signifi cant social and economic costs to Russiansociety. However, ratifi cation of the World health organization Framework conventionon tobacco control makes it possible to improve Russian legislation accordingto the international standards. So, I describe some measures that should be taken bythe Russian authorities in the nearest future, and I examine their effi ciency. By studyingthe international evidence I analyze the impact of the smoke-free areas, advertisementand sponsorship bans, tax increases, etc. on the prevalence of smoking, cigaretteconsumption and some other indicators. I also investigate the obstacles confrontingthe Russian authorities when they introduce new policy measures and the public attitudetowards these measures. I conclude that there is a number of easy-to-implementanti-smoking activities that need no fi nancial resources but only a political will.
One of the most important indicators of company's success is the increase of its value. The article investigates traditional methods of company's value assessment and the evidence that the application of these methods is incorrect in the new stage of economy. So it is necessary to create a new method of valuation based on the new main sources of company's success that is its intellectual capital.